Antibe Therapeutics Inc - ESG Rating & Company Profile powered by AI
Full Sustainability assessment of Antibe Therapeutics Inc can be reached by signing up for free. This webpage displays a free ESG report covering Antibe Therapeutics Inc. If you are employed by Antibe Therapeutics Inc and you would like to licence your ESG rating, please get in touch.
Antibe Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 8.0, social score of 5.3 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 217 | Takara Bio Inc | 7.2 | High |
| 217 | Ultragenyx Pharmaceutical Inc | 7.2 | High |
| 224 | Antibe Therapeutics Inc | 7.1 | High |
| 224 | Celularity Inc | 7.1 | High |
| 224 | Bilcare Ltd | 7.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Antibe Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Antibe Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Antibe Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Antibe Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Antibe Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Antibe Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Antibe Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Antibe Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Antibe Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Antibe Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Antibe Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Antibe Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Antibe Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Antibe Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Antibe Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Antibe Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Antibe Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Antibe Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating post-operative pain, migraine, dysmenorrhea, traumatic injury, dental pain, and gout that has completed Phase 2B gastrointestinal safety study. In addition, the company's products comprise ATB-352, which is in preclinical stage for acute pain. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada.